Dark Forest Capital Management LP Neurocrine Biosciences Inc Transaction History

Dark Forest Capital Management LP

  • $718 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$94.02 - $117.1 $833,393 - $1.04 Million
8,864 New
8,864 $997,000
Q1 2023

May 12, 2023
BUY
$94.11 - $123.02 $149,729 - $195,724
1,591 New
1,591 $161,000
Q4 2021

Feb 11, 2022
SELL
$79.65 - $106.22 $8,442 - $11,259
-106 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$86.18 - $99.03 $9,135 - $10,497
106 New
106 $10,000

Others Institutions Holding NBIX

# of Institutions
635
Shares Held
93.5M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $14.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email